Compare tickers
Up to 5 tickers, ~30 metrics, weighted verdict. Best in green, worst in red.
Verdict
Weighted score 0-100 across 1 tickers · best in green
25
25
15
20
15
Total: 100 · normalized in scoring
#1
VRTX
score 50.0
Weakest momentum with negative 10.46% three-month return drags down otherwise balanced scores across all weighted categories.
value 50growth 50quality 50momentum 50sentiment 50
VRTX
Vertex Pharmaceuticals Incorporated
$427.92
+0.66%
VRTX
Vertex Pharmaceuticals Incorporated
$427.92
+0.66%
Snapshot
Price
427.92
Day %
0.66
1M %
-0.45
3M %
-10.46
YTD %
-5.36
Market cap
108607152128.0
ADV ($)
556265547.8679199
Beta
0.301
Tao zone
Current zone
Pullback
Dist 21-EMA %
-1.88
Dist ATR (σ)
-0.76
Tao grade
C
Confluence
3
Valuation
P/E (ttm)
25.425728
P/E (fwd)
19.929218
P/S
8.889111
EV/EBITDA
20.603
P/B
5.6172304
FCF yield
0.0256
PEG
1.68
Growth
Revenue yoy
0.078
EPS yoy
0.614
FCF yoy
—
Quality
Gross margin
0.54390997
Operating margin
0.38126
Net margin
0.35507
ROE
0.24197
ROA
0.12142
Debt / Equity
0.1
Interest cov.
350.11
Technicals
RSI(14)
43.4
MACD signal
bear
vs 50-DMA
-2.13
vs 200-DMA
-2.0
vs 52w high
-15.75
HV-30
22.2
Sentiment
Analyst rec
1.60606
Target upside
28.22
Insider buy-sell 90d
—
Risk
Short interest
1.9900000000000002
Days to cover
3.97
Next earnings
2026-08-03
Full VRTX dashboard →